Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is June 13, 2025, covering share purchases executed on June 12, 2025. The transaction was conducted through Merrill Lynch International as part of GSK's existing share buyback programme.
Key Financial Metrics
The filing details specific share repurchase activity rather than operational financial results (revenue, profit, or cash flow).
- Shares Purchased (June 12, 2025): 317,488 ordinary shares.
- Price Range: Lowest price paid was 1,524.00 GBp; highest price paid was 1,556.50 GBp.
- Volume-Weighted Average Price: 1,545.55 GBp.
- Trading Venue: London Stock Exchange (XLON).
- Cumulative Buyback (since June 4, 2025): 2,454,275 ordinary shares.
- Treasury Shares Held: 220,588,658 ordinary shares.
- Shares in Issue (excluding Treasury): 4,094,694,253 ordinary shares.
- Treasury Voting Rights: 5.39% of total voting rights.
Material Changes
The filing does not provide comparative financial data (e.g., revenue or profit changes) against prior periods. The material change reported is the reduction of shares in issue and the increase in treasury shares resulting from the buyback programme initiated on June 4, 2025.
Guidance, Outlook, and Risks
The filing contains no new financial guidance or management commentary regarding operational outlook. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties. Investors are directed to the "Risk Factors" section of GSK's Annual Report on Form 20-F for 2024 and Q1 Results for 2025 for details on potential risks.
Investor Verification Checklist
- Verify the total number of shares in issue (4,094,694,253) for calculating ownership thresholds under FCA Disclosure Guidance and Transparency Rules.
- Confirm the percentage of voting rights held in treasury (5.39%) to assess potential dilution or capital structure changes.
- Review the non-discretionary agreement terms announced on June 4, 2025, to understand the scope and duration of the buyback programme.
- Check the volume-weighted average price (1,545.55 GBp) against current market prices to evaluate the efficiency of the repurchase.